“Papillomavirus Capsid Proteins”
Decision of the Paris Court of Appeal (Cour d’appel de Paris) 12 April 2016 – Case No. RG 2015/12234; B20160042
Decision • Patent Law France
- 66 Downloads
A different manufacturing method does not justify the grant of an additional SPC for the same active ingredient.
KeywordsSupplementary protection certificate (SPC) Active ingredient Manufacturing method
© Max Planck Institute for Innovation and Competition, Munich 2017